Frequent co-amplification of two different regions on 17q in aneuploid breast carcinomas

Cancer Genetics and Cytogenetics

Volumn 127, Issue 1, 2001, Pages 16-23

  Latham, Carolyn ^a   Zhang, Anju ^a   Nalbanti, Aspasia ^a   Månér, Susanne ^a   Zickert, Peter ^a   Blegen, Harald ^a   Zetterberg, Anders ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GENETICS; CHROMOSOME 17Q; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENE AMPLIFICATION; GENE CLUSTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE C ERB; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANEUPLOIDY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; CHROMOSOMES, HUMAN, PAIR 17; DNA PRIMERS; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENES, ERBB-2; HUMANS; IMMUNOENZYME TECHNIQUES; PLACENTAL LACTOGEN; POLYMERASE CHAIN REACTION; PROGNOSIS; SEQUENCE ANALYSIS, DNA;

EID: 0035335639     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(00)00427-1     Document Type: Article

References (37)

1. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene
2. Assignment of v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (ERBB2) to human chromosome band 17q21.1 by in situ hybridization
3. Human breast cancer:correlation of relapse and survival with amplification of the HER-2/neu oncogene
4. ERBB2 oncogene in human breast cancer and its clinical significance
5. Characterization of topoisomerase IIα gene amplification and deletion in breast cancer
6. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization
7. Comparative genomic hybridization of formalin-fixed, paraffin embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas
8. Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted
9. Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis
10. Frequent allelic loss at the TOC locus on 17q25.1 in primary breast cancers
11. The BRCA1 and BRCA2 breast cancer genes
12. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons
13. Common fragile sites and cancer
14. Fragile sites still breaking
15. Increased copy number at 17q22-q24 by CGH in breast cancer is due to hugh-level amplification of two separate regions
16. Chromosomal localization of the human placental lactogen-growth hormone gene cluster to 17q22-24
17. Cloning mammary cell DNAs from 17q12-q23 using interspecific somatic cell hybrids and subtractive hybridization
18. Analysis of a major human chorionic somatomammotropin gene, evidence for two functional promoter elements
19. The human growth hormone locus; nucleotide sequence, biology and evolution
20. The human placental lactogen genes; structure, function, evolution and transcriptional regulation
21. Comparative aspects of placental lactogens; structure and function
22. Hormonal and cell-specific regulation of the human growth hormone and chorionic somatomammotropin genes
23. Precise localization of the gene for platelet membrane glycoprotein IIb to 17q21.32 using structural rearrangements of chromosome 17
24. Organization of the gene for platelet glycoprotein IIb
25. Relationship between oncogene amplification, aneuploidy and altered expression of p53 in breast cancer
26. Tumor marker expression in breast carcinomas and relationship to prognosis. An immunohistochemical study
27. Expression of the gene encoding growth hormone in the human mammary gland
28. Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture
29. Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines
30. BRCA1 mutations in primary breast and ovarian carcinomas
31. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
32. Tumor-associated antigens in breast carcinomas - prognostic significance
33. Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer
34. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis
35. Multiple genes at 17q23 undergo amplification and overexpression in breast cancer
36. 17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGmal1B genes